Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Triamcinolone for Carpal Tunnel Syndrome
NCT05624866Unknown
- Sponsor
- Assiut University
- Start
- Oct 2022
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of dexmedetomidine in carpal tunnel syndrome (CTS), sponsored by Assiut University. Primary endpoint: Visual Analog Scale at 6 months. Status: unknown.
02
Drugs
dexmedetomidine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on NCT05624866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05624866.